Seattle biotech firm Impel NeuroPharma files for $75M IPO

Impel CEO Adrian Adams. (Impel Photo) Seattle-based biotech company Impel NeuroPharma is set to go

Read the full article at contacted.org...

Found and curated by

SMB

Comments

Popular posts from this blog

New Challenges to Operational Efficiencies Because of COVID Protocols

Becoming a Coach Trainer